azd4635
azd4635: 1 clinical trial tracked.
azd4635 evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about azd4635, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trials (1)
A Multiarm, Open-label, Multicenter, Phase 1b/2 Study to Evaluate Novel Combination Therapies in Subjects With Previously Treated Advanced EGFRm NSCLC
Primary endpoint: Number of Participants With Dose-limiting Toxicities (DLTs) in Part 1
Interventionalopen43 enrolledStarted 2018-05Completion 2026-1113 sites · South Korea, Taiwan, United StatesMedImmune LLC